Our Science – Rudloff Website
Udo Rudloff, M.D., Ph.D.
Dr. Rudloff's clinical interests lie in the management of complex cancers of the liver, biliary tree, and pancreas. His laboratory efforts focus on preclinical drug development for pancreatic cancer and other GI malignancies in vitro and in vivo models, and the design of personalized treatment strategies for the individual genotype of patients' tumors.
This page was last updated on 12/2/2013.